Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT for Chemotherapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where ROLAPITANT was used for Chemotherapy.

Most Reported Side Effects for ROLAPITANT

Side Effect Reports % Deaths Hosp.
Death 241 27.6% 241 12
Flushing 92 10.5% 0 3
Nausea 80 9.2% 4 14
Dyspnoea 74 8.5% 1 8
Infusion related reaction 65 7.5% 0 3
Erythema 54 6.2% 0 2
Feeling hot 47 5.4% 0 1
Dizziness 45 5.2% 1 4
Hospitalisation 36 4.1% 3 36
Back pain 32 3.7% 0 1
Chest discomfort 30 3.4% 0 1
Fatigue 30 3.4% 0 2
Abdominal discomfort 29 3.3% 0 0
Chest pain 28 3.2% 1 4
Malaise 26 3.0% 5 10

Other Indications for ROLAPITANT

Nausea (536) Vomiting (533) Product used for unknown indication (107) Prophylaxis of nausea and vomiting (46) Ovarian cancer (17) Plasma cell myeloma (17) Uterine cancer (10) Antiemetic supportive care (6)

Other Drugs Used for Chemotherapy

CYCLOPHOSPHAMIDE (3,372) DOCETAXEL (2,134) CARBOPLATIN (1,902) DOXORUBICIN (1,756) VINCRISTINE (1,743) PACLITAXEL (1,425) OXALIPLATIN (1,423) METHOTREXATE (1,380) CYTARABINE (1,355) ETOPOSIDE (1,246)

Related Pages

ROLAPITANT Full Profile All Chemotherapy Drugs ROLAPITANT Demographics ROLAPITANT Timeline